InvestorsHub Logo
Followers 4
Posts 1197
Boards Moderated 0
Alias Born 10/03/2015

Re: jondoeuk post# 268

Wednesday, 04/26/2023 9:29:34 PM

Wednesday, April 26, 2023 9:29:34 PM

Post# of 394
Some CEOs won't even PR. AFMD was a tool company so learning to cure will be tough sledding. I will take the working ICEs over some nice CEO any day. If you look at ASCO release today, there will be some nice nuggets coming from SAR443579. a trifunctional Natural Killer Cell Engager (NKCE) targeting the CD123 tumor antigen on cancer cells. I guess 30% ORR got the NKCE the oral session. It looks like AFM24 - ADCP.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News